Detection of Extended Spectrum Beta-lactamase Gene (CTX-M) among Representative Multidrug-Resistant Gram-negative Bacterial Isolates from Patients with Urinary Tract Infections
Ayodele Oluwaseun Ajayi *
Department of Microbiology, Federal University, Oye Ekiti, Ekiti State, Nigeria.
Samuel Ayodeji Osanyinlusi
Department of Microbiology, Federal University, Oye Ekiti, Ekiti State, Nigeria.
Oluwabukola Atinuke Popoola
Genetics, Genomics and Bioinformatics, National Biotechnology Development Agency, Abuja, Nigeria.
Bryan Ogeneh
Department of Microbiology, Federal University, Oye Ekiti, Ekiti State, Nigeria.
*Author to whom correspondence should be addressed.
Abstract
Urinary tract infection (UTI) is a huge public health problem and the emergence of extended spectrum-beta-lactamase producing bacterial pathogens increases the burden of infectious diseases in Nigeria. This study determined the current prevalence of cephalosporin resistance among Gram-negative bacteria isolated from patients with urinary tract infections between February 2018 and June 2018. This study was aimed to determine cephalosporin resistance prevalence among Gram-negative bacteria isolated from patients with urinary tract infections between February 2018 and June 2018. A total number of forty representative Gram-negative bacterial isolates namely Escherichia coli (n=14), Klebsiella pneumonia (n=9), Proteus mirabilis (n=12), and Klebsiella oxytoca (n=5) were subjected to polymerase chain reaction (PCR) to detect extended spectrum beta-lactamase (ESBL) genes using primers specific for blaTEM, blaSHV and blaCTX-M. The molecular evaluation indicated the presence of blaCTX-M gene in 20.0% of the tested organisms, while other ESBL genes variants were not detected. The organisms carrying the blaCTX-M gene included E. coli (n=3, 37.5%), K. pneumoniae (n=1, 12.5%), P. mirabilis (n=1, 12.5%),) and K. oxytoca (n=3, 37.5%). The presence of cephalosporin resistant Gram-negative bacteria among patients with UTI may constitute a serious threat to public health and efforts must be intensified to regulate the clinical use of the cephalosporins.
Keywords: UTI, E. coli, ESBL, antibiotics